Long-term effects of statins on arterial pressure and stiffness of hypertensives (Q45054591)

9 December 2017

Long-term effects of statins on arterial pressure and stiffness of hypertensives (English)

1 reference

9 December 2017

Ichihara A

1

1 reference

9 December 2017

Hayashi M

2

1 reference

9 December 2017

Koura Y

3

1 reference

9 December 2017

Tada Y

4

1 reference

9 December 2017

Kaneshiro Y

5

1 reference

9 December 2017

Saruta T

6

1 reference

9 December 2017

1 February 2005

1 reference

Journal of Human Hypertension

9 December 2017

1 reference

9 December 2017

19

1 reference

9 December 2017

2

1 reference

9 December 2017

103-109

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001786

9 December 2017

0 references

cites work

Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Long-term effects of intensive blood-pressure lowering on arterial wallstiffness in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Effects of initial and long-term lipid-lowering therapy on vascular wall characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Antioxidative effects of fluvastatin and its metabolites against oxidative DNA damage in mammalian cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Simvastatin improves endothelial function in spontaneously hypertensive rats through a superoxide dismutase mediated antioxidant effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

7 January 2021

Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

7 January 2021

Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

7 January 2021

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

7 January 2021

Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

7 January 2021

Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

7 January 2021

Pro-apoptotic effect of fluvastatin on human smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

7 January 2021

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

7 January 2021

Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

7 January 2021

Direct effects of statins on the vascular wall

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

7 January 2021

Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

7 January 2021

Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

7 January 2021

C-reactive protein and progressive atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001786

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001786

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference